Literature DB >> 23780921

Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.

Snjezana Dogan1, Matthew L Hedberg, Robert L Ferris, Tanya J Rath, Adel M Assaad, Simion I Chiosea.   

Abstract

BACKGROUND: The significance of human papillomavirus (HPV) in nasopharyngeal carcinomas (NPCs) in a low-incidence population remains unknown.
METHODS: Samples from 90 patients with NPC (years, 1957-2012) were analyzed for Epstein-Barr virus (EBV). Clinical data, EBV, HPV, and p16 status were correlated with overall survival (OS; 63 cases; years, 1981-2012).
RESULTS: Of 9 HPV-positive cases, 3 extended from extra-nasopharyngeal sites. Nasopharyngeal origin was confirmed in 6 cases. HPV-positive NPC had OS similar to EBV-positive NPC (85 vs 141 months; p > .05). The OS of patients with EBV/HPV-negative NPC was worse (34 months; p = .004). Nonkeratinizing histology was associated with better outcome than keratinizing (115 vs 25 months; p = .001). Over the last several decades, the proportion of keratinizing NPC decreased from 34.5% to 14.3% (p = .026).
CONCLUSION: The etiologic role of HPV in NPC is confirmed. The favorable prognostic significance of HPV positivity is similar to that of EBV positivity.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epstein-Barr virus; human papillomavirus; nasopharyngeal carcinoma

Mesh:

Year:  2013        PMID: 23780921      PMCID: PMC4656191          DOI: 10.1002/hed.23318

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  27 in total

1.  Pathology archive: evaluation of integrity, regulatory compliance, and construction of searchable database from print reports.

Authors:  Matthew A Smith; E Leon Barnes; Simion I Chiosea
Journal:  Am J Clin Pathol       Date:  2011-05       Impact factor: 2.493

2.  Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: a Serbian report.

Authors:  T T Terzic; M I Boricic; I P Pendjer; D T Ruzic Zecevic; N R Tomanovic; D C Brasanac; I V Boricic
Journal:  Med Oncol       Date:  2010-05-06       Impact factor: 3.064

3.  Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.

Authors:  Aatur D Singhi; William H Westra
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

4.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

5.  Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity.

Authors:  Samir K El-Mofty; Danielle W Lu
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

6.  Human papillomavirus and WHO type I nasopharyngeal carcinoma.

Authors:  Emily J Lo; Diana Bell; Jason S Woo; Guojun Li; Ehab Y Hanna; Adel K El-Naggar; Erich M Sturgis
Journal:  Laryngoscope       Date:  2010-10       Impact factor: 3.325

7.  Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population.

Authors:  Jerry Polesel; Silvia Franceschi; Renato Talamini; Eva Negri; Luigi Barzan; Maurizio Montella; Massimo Libra; Emanuela Vaccher; Giovanni Franchin; Carlo La Vecchia; Diego Serraino
Journal:  Oral Oncol       Date:  2011-04-07       Impact factor: 5.337

8.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

Review 9.  Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

Authors:  Erich M Sturgis; Paul M Cinciripini
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

10.  HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.

Authors:  Jessica H Maxwell; Bhavna Kumar; Felix Y Feng; Jonathan B McHugh; Kitrina G Cordell; Avraham Eisbruch; Francis P Worden; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Theodoros N Teknos; Douglas B Chepeha; Jay Stoerker; Heather Walline; Thomas E Carey; Carol R Bradford
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

View more
  22 in total

Review 1.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 2.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 3.  The interaction between human papillomavirus and other viruses.

Authors:  J T Guidry; R S Scott
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

Review 4.  The sinonasal tract: another potential "hot spot" for carcinomas with transcriptionally-active human papillomavirus.

Authors:  James S Lewis; William H Westra; Lester D R Thompson; Leon Barnes; Antonio Cardesa; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Asterios Triantafyllou; Julia A Woolgar; Kenneth O Devaney; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2013-12-14

5.  The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.

Authors:  Carole Fakhry; William H Westra; Steven J Wang; Annemieke van Zante; Yuehan Zhang; Eleni Rettig; Linda X Yin; William R Ryan; Patrick K Ha; Alicia Wentz; Wayne Koch; Jeremy D Richmon; David W Eisele; Gypsyamber D'Souza
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 6.  Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Authors:  Peter P Luk; Christina I Selinger; Wendy A Cooper; Annabelle Mahar; Carsten E Palme; Sandra A O'Toole; Jonathan R Clark; Ruta Gupta
Journal:  Head Neck Pathol       Date:  2018-11-22

7.  Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.

Authors:  Hong Li; Sina J Torabi; Wendell G Yarbrough; Saral Mehra; Heather A Osborn; Benjamin Judson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-06-01       Impact factor: 6.223

8.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

Authors:  Matthew H Stenmark; Jonathan B McHugh; Matthew Schipper; Heather M Walline; Christine Komarck; Felix Y Feng; Francis P Worden; Gregory T Wolf; Douglas B Chepeha; Mark E Prince; Carol R Bradford; Suresh K Mukherji; Avraham Eisbruch; Thomas E Carey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

9.  Human papillomavirus and Epstein Barr virus in head and neck carcinomas: suggestions for the new WHO classification.

Authors:  James S Lewis; Rebecca D Chernock
Journal:  Head Neck Pathol       Date:  2014-03-05

10.  Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.

Authors:  Justin A Bishop; Lisa M Rooper; Simion I Chiosea; William H Westra
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.